Improve Your Laboratory’s Efficiency
By starting with blood culture results you can trust.
Your Time is Valuable; Don’t Waste It Running Unnecessary Tests
Laboratory results drive clinical patient care decisions in your hospital and the productivity of your laboratory affects the performance of the entire hospital. False-positive blood cultures caused by contamination tax laboratory operations and resources with additional workups and tests for nearly half of positive blood culture results.46
Negatively impacts workflow
Unnecessary tests
Negatively Impacts process and productivity
Major contributor to overtime
Significantly increases avoidable costs
Process Blood Cultures Efficiently, Effectively, and Confidently with Steripath®
Disruptive testing errors can be avoided with Steripath, which has been FDA 510(k)-cleared with a specific indication to reduce blood culture contamination.47
What does this mean for a typical hospital that performs 20,000 blood cultures each year and has a 3% contamination rate?
48 / month
Total gained patient tests processed.
578 / year
Total gained patient tests processed.
37,000 minutes
Total annual saved processing time.
500 fewer false positives
Net reduction in blood culture contamination.
Steripath has been clinically proven to achieve sustained results of near-zero blood culture contamination rates48
This 1% performance level is now consistent with the new goal, with best practices, included in the Clinical Laboratory Standards (CLSI) M47 Principles and Procedures for Blood Cultures, 2nd Edition 2022.
Using Steripath helps your laboratory prepare for the introduction of new standards and drastically reduces the number of unnecessary tests to improve workflow and productivity, so you can feel confident you’re delivering the most accurate, reliable results – every time.
Steripath® ISDD® empowered Opelousas General Health System to achieve unexpected success in reaching the unprecedented goal of a blood culture contamination rate of <1% only 3 months after implementation.
“
Jerry Besson MS, BB(ASCP), CLS(LSBME)
Manager of Laboratory Services
Steripath® ISDD® is the evidence-based technology solution to a problem many thought could never be solved.
A sustained 1% or less blood culture contamination rate is now achievable.
“
Dennis Ernst, MT(ASCP), NCPT(NCCT)
Pre-Analytic Consultant
Former Founding Director
Center for Phlebotomy Education
Phlebotomy Today
The Phlebotomy Channel
The initial allure of the Steripath® Initial Specimen Diversion Device® was its proven ability to reduce blood culture contamination. However, during the implementation phase, we discovered that the device’s quantitative effectiveness was paralleled by Magnolia Medical’s qualitative excellence. Magnolia Medical has continued to share in our commitment to success.
Their level of engagement throughout our ongoing project demonstrated that they take pride in their products as well as their clinical expertise, leveraging both to take hospitals to the next level with respect to best practices in blood culture collection. Other institutions considering adopting Steripath should be confident that they will be partnering with a company that has a vested interest in optimizing success for all stakeholders.
“
Todd M. Lasco, Ph.D., D(ABMM)
Assistant Professor, Baylor College of Medicine
Scientific Director, Microbiology, Immunology & Molecular Pathology
Time and time again, Steripath® ISDD® has been shown to be an amazing solution to deliver sustained reduction in contamination rates below 1%.
I am a big fan. Steripath is an extremely cost-effective and elegantly engineered solution to a problem that has existed for decades. We are seeing actual results that prevent patient harm and directly drive antibiotic stewardship.
“
Shanise Keith, NCPT(NHA)
Director
Center for Phlebotomy Education
Phlebotomy Today
The Phlebotomy Channel
Clinical Performance Guarantee
Every Steripath device is backed by our Clinical Performance Guarantee. Reduce blood culture contamination rates at your hospital by at least 50%, or get your money back.
(Additional terms and conditions may apply)
We’re on a mission to improve the diagnostic accuracy and timeliness of sepsis test results.